The hearing implant maker’s shares cratered to the lowest level since April 2016 amid the Middle East conflict and plunging ...

Cochlear also said that trading conditions for implants in developed markets have been softer-than-expected, while the fourth ...

Cochlear’s shares have collapsed after the hearing implants behemoth again downgraded profit guidance by up to $170m on ...

Cochlear Ltd (ASX: COH) shares have plunged more than a third after the company announced a massive downgrade in expected ...

Cochlear reduces its FY26 earnings guidance amid softer implant sales, ongoing challenges in key markets, and a focus on long ...

Cochlear, an Australian hearing implant manufacturer, has slashed its 2026 earnings forecast due to the Middle East conflict, resulting in a nearly 39% drop in share value. The turmoil has affected ...

Iran tensions; Cochlear smashed on profit warning; Treasury Wine soars on restructure; Corporate Travel flags $222m revenue ...

Cochlear Ltd has updated its trading performance, reducing its FY26 earnings guidance to A$290-330 million. The company anticipates a 2-6% sales growth in the second half, in constant currency.

The 1960s were a particularly fruitful time for words abundant in our lexicon today. Scientific advancements gave rise to new ...

A patient with sudden hearing loss was diagnosed with SNHL at an ENT clinic in South Delhi and treated by Dr. Purodha Prasad ...

Hearing implant maker Cochlear has slashed its FY26 earnings guidance, citing softer-than-expected sales in the third quarter ...

A 2026 informational overview of EchoXen ear drops, including the 18-ingredient hearing-support formulation, how the product ...